Important parameters for platinum(IV) anticancer drug development
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Subcellular imaging of a dual stable isotope-labeled platinum(IV) complex in murine tumor
Anton Legin (Speaker), Christian Kowol (Contributor), Arno Schintlmeister (Contributor), Hemma Schueffl (Contributor), Walter Berger (Contributor), Petra Heffeter (Contributor) & Bernhard Keppler (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Evaluation of two albumin-targeting moieties as in situ binders in comparison to maleimide
Anja Federa (Speaker), H. Schueffl (Contributor), Alexander Kastner (Contributor), Julia Kronberger (Contributor), Bernhard Keppler (Contributor), Thomas Mindt (Contributor), P. Heffeter (Contributor) & Christian Kowol (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Elemental analysis: Essential purity control but prone to manipulations
Wolfgang Kandioller (Contributor), Johannes Theiner (Contributor), Bernhard Keppler (Contributor) & Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Impact of albumin-targeting on the anticancer activity and tumor distribution of platinum(IV) prodrugs
Hemma Schueffl (Contributor), Sarah Theiner (Contributor), Oliver Baumfried (Contributor), Gunda Köllensperger (Contributor), Anton Legin (Contributor), Bernhard Keppler (Contributor), Walter Berger (Contributor), Christian Kowol (Invited speaker) & Petra Heffeter (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Anticancer drug development: a chemist´s view
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Impact of albumin-targeting on the pharmacology, tissue distribution and anticancer activity of an oxaliplatin(IV) bismaleimide prodrug in vivo
Hemma Schueffl (Speaker), Sarah Theiner (Contributor), Gunda Köllensperger (Contributor), Bernhard Keppler (Contributor), Walter Berger (Contributor), Christian Kowol (Contributor), Anton Legin (Contributor) & Petra Heffeter (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Crucial Parameters for Platinum(IV) Anticancer Drug development
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Hydrolysis of equatorial ligands of platinum(IV) complexes
Alexander Kastner (Keynote speaker), Isabella Pötsch (Contributor), Petra Heffeter (Contributor), Bernhard Keppler (Contributor) & Christian Kowol (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Crucial parameters for platinum(IV) anticancer drug development
Christian Kowol (Keynote speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Aquation of equatorial ligands of Pt(IV) complexes under physiological conditions
Christian Kowol (Keynote speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Albumin-targeted platinum(IV) complexes with outstanding antitumor activity in vivo
Christian Kowol (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Prodrugs and Tumor-specific Activation
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Distinctly enhanced anticancer activity in vivo by albumin-targeted platinum(IV) prodrugs
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Metallomics and metabolomics studies in preclinical anticancer research of oxaliplatin
Luis Galvez (Speaker), Michaela Schwaiger (Contributor), Sonja Hager (Contributor), Christian Kowol (Contributor), Petra Heffeter (Contributor), Walter Berger (Contributor) & Gunda Köllensperger (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Albumin-based tumor-targeted platinum(IV) prodrugs with distinctly enhanced anticancer activity in vivo
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Understanding the metabolism of the anticancer drug Triapine by application of electrochemistry and liquid chromatography coupled to mass spectrometry
Karla Pelivan (Speaker), Lisa Frensemeier (Contributor), Uwe Karst (Contributor), Gunda Köllensperger (Contributor), Björn Bielec (Contributor), Petra Heffeter (Contributor), Christian Kowol (Contributor) & Bernhard Keppler (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Maleimid-functionalized Platinum(IV) complexes for tumor-Targeted Drug Delivery
Christian Kowol (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
Tyrosine-kinase receptor targeted platinum(IV) complexes
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
Prodrugs as the next step in drug development
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Prodrug strategies for tumor-specific anticancer activity
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
A COBALT-BASED PRODRUG STRATEGY FOR TUMOR-TARGETING OF EGFR-INHIBITORS
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
The search for novel anticancer drugs
Christian Kowol (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Other
Development and optimization of multifunctional nanoparticles for molecular imaging and therapy
Christian Kowol (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Other
Tuning drug ratios in multi-action platinum(IV) therapeutics
Kowol, C. & Heffeter, P.
Project: Research funding
Marker für die Aktivität von Albumin-bindenden Verbindungen
Heffeter, P., Mindt, T. & Kowol, C.
1/08/20 → 31/07/24
Project: Research funding
The tumor microenvironment as target and regulator of anticancer (metal) drug response
1/04/20 → 31/03/25
Project: Research funding
Nanocarrier for Tumor-Specific Anticancer Thiosemicarbazones
Kowol, C., Heffeter, P. & Teasdale, I.
1/05/19 → 30/04/23
Project: Research funding
Department of Inorganic Chemistry
Head
Währinger Straße 42
1090 Wien
Room: 2164
T: +43-1-4277-52611